Free Depression Test Online | Test Bipolar Depression

What the PHQ-9 Actually Measures

The PHQ-9 was designed to operationalise the DSM diagnostic criteria for Major Depressive Disorder into a brief, practical screening tool. Each of the nine items maps directly onto one of the nine diagnostic criteria: depressed mood, anhedonia (loss of interest or pleasure), sleep disturbance, fatigue, appetite or weight change, feelings of worthlessness or guilt, concentration difficulties, psychomotor changes (slowing or agitation), and thoughts of death or suicide.

The scoring produces five severity bands: minimal (0-4), mild (5-9), moderate (10-14), moderately severe (15-19), and severe (20-27). These thresholds were established through validation research across large primary care populations and have been confirmed as clinically meaningful decision points. A score of 10 or above is widely used as the threshold for initiating treatment discussions in clinical practice.

One dimension that makes the PHQ-9 particularly useful is the final question about functional impairment — how much any of the symptoms have made it difficult to work, manage home responsibilities, or get along with others. Depression is defined not just by symptom presence but by the degree to which those symptoms impair functioning. A symptom that is present but causes no functional impairment is clinically different from one that significantly disrupts daily life.

What Depression Actually Feels Like — Beyond the Textbook

The clinical description of depression — persistent low mood, loss of interest, sleep and appetite changes, concentration problems — is accurate but can make the experience sound more manageable than it often is. Understanding what depression actually feels like from the inside helps explain why people with depression often cannot simply "decide to feel better" or "focus on the positive."

Anhedonia — the loss of the capacity for pleasure — is often described by people with depression as the most alien and frightening symptom. It is not that things that used to bring joy now produce sadness. It is that they produce nothing. Food has no taste. Music that once moved you is just noise. Activities you used to love feel like obligations you cannot execute. The world becomes flat. This absence of positive emotion is neurobiologically distinct from the presence of negative emotion, and it is often more disabling.

Cognitive impairment is frequently underestimated by people outside depression. Depression reliably impairs working memory, processing speed, and executive function. Simple decisions become overwhelming. Reading comprehension drops. People describe feeling like they are thinking through treacle. This cognitive fog is real, measurable in neuropsychological testing, and can make seeking help — which requires initiative, research, and phone calls — feel virtually impossible.

Guilt and worthlessness in depression are not rational responses to actual failures. They are cognitive distortions generated by a depressed brain that interprets neutral or ambiguous information through a consistently negative lens. People with depression often describe feeling that they are a burden to everyone around them, that they have wasted their potential, that they do not deserve help. These thoughts are symptoms of the illness — not accurate assessments of reality.

Depression Subtypes: Why One Size Does Not Fit All

Depression is not a single uniform condition. Understanding the different presentations helps explain why the same symptoms can look very different in different people, and why treatment approaches sometimes need to be tailored.

Major Depressive Disorder (MDD) is the most commonly diagnosed form — discrete episodes of significant depression, typically lasting months, against a baseline of normal mood. Most of what is described as "clinical depression" falls into this category.

Persistent Depressive Disorder (PDD, formerly Dysthymia) is a chronic, lower-grade depression lasting two years or more without full remission. People with PDD often do not identify themselves as depressed because the low mood feels like their personality rather than a superimposed illness. "I've always been a pessimist" or "I've never really been happy" are common descriptions. PDD is associated with significant impairment and responds to the same treatments as MDD, though often more slowly.

Postpartum Depression affects approximately 10-15% of women after childbirth and a significant proportion of partners. It is biologically distinct from the normal emotional adjustment of new parenthood (the "baby blues," which resolve within two weeks). Postpartum depression involves the full MDD symptom picture, can include intrusive thoughts about harming the baby, and requires prompt treatment. The PHQ-9 is validated for postpartum depression screening.

Seasonal Affective Disorder (SAD) involves depressive episodes that follow a predictable seasonal pattern, most commonly developing in autumn and winter and remitting in spring. It is thought to be driven by disruption of circadian rhythms and melatonin regulation in response to reduced daylight. Light therapy (10,000 lux broad-spectrum light for 20-30 minutes in the morning) is a first-line treatment alongside the standard depression approaches.

High-functioning depression is not a formal diagnostic term, but it describes a real and commonly experienced pattern: people who maintain work performance, social obligations, and outward appearances while privately experiencing significant depression. They are often the last people anyone would identify as depressed. This pattern is particularly associated with perfectionism, high achievers, and people in roles where vulnerability feels dangerous.

The Neuroscience of Depression: What Is Actually Happening in the Brain

Depression is often described as a "chemical imbalance" — an oversimplification that is simultaneously too reductive and occasionally useful. The full neurobiological picture is considerably more complex and actually helps explain both why depression feels the way it does and why treatment takes time to work.

Monoamine dysregulation involves changes in serotonin, norepinephrine, and dopamine signalling. This is the mechanism that most antidepressants target — SSRIs increase serotonin availability, SNRIs increase both serotonin and norepinephrine, and bupropion primarily affects dopamine and norepinephrine. However, the monoamine hypothesis alone is insufficient: increasing serotonin availability happens within hours of taking an SSRI, but the antidepressant effect takes 4-6 weeks. This gap suggests the therapeutic mechanism involves downstream neuroplasticity changes rather than monoamine levels themselves.

HPA axis dysregulation — the same stress hormone system involved in burnout — is a consistent finding in depression. Elevated cortisol in depression damages the hippocampus (the brain's primary memory structure), which helps explain the cognitive impairment and may contribute to the negative memory bias characteristic of depression.

Neuroinflammation is increasingly recognised as a component of depression, particularly in treatment-resistant cases. People with elevated inflammatory markers respond better to anti-inflammatory interventions and may respond less well to standard antidepressants. This has important implications for treatment selection.

Neuroplasticity — the brain's ability to form new connections and pathways — is impaired in depression. BDNF (brain-derived neurotrophic factor) levels drop. The prefrontal cortex (responsible for rational thinking and emotional regulation) shows reduced activity and connectivity. Exercise, therapy, and antidepressants all increase BDNF and promote neuroplasticity, which is why lifestyle interventions have genuine neurobiological effects rather than being merely "mind over matter."

Treatment That Actually Works: An Evidence-Based Overview

Depression has more treatment options with strong evidence than almost any other mental health condition. The challenge is not that treatments are unavailable — it is that people often wait too long before accessing them, or try one approach for too short a period before concluding it is not working.

Cognitive Behavioural Therapy (CBT) is the most extensively studied psychological treatment for depression, with a larger evidence base than any other specific therapy type. It addresses the cognitive distortions and behavioural patterns that maintain depression — specifically the cycles of negative thinking, avoidance, and reduced activity that prevent recovery. Structured CBT typically runs 12-20 sessions. Importantly, CBT produces changes in brain activity that are measurable on neuroimaging and are distinct from those produced by medication — suggesting the two approaches work through complementary pathways.

Interpersonal Therapy (IPT) focuses on the relationship context of depression — specifically on unresolved grief, role transitions, interpersonal disputes, and social isolation. It has strong evidence particularly for depression arising in the context of relationship problems or life changes.

Behavioural Activation is a component of CBT that can also stand alone as an intervention. Depression produces a withdrawal pattern — reduced activity, social isolation, avoidance of previously enjoyable activities. This reduced engagement perpetuates depression. Behavioural Activation systematically increases engagement with meaningful and pleasurable activities, even when motivation is absent. The insight is that motivation follows action in depression more reliably than action follows motivation.

Antidepressant medication is effective for moderate to severe depression, with the evidence strongest at higher severity levels. The SSRIs (selective serotonin reuptake inhibitors) and SNRIs (serotonin-norepinephrine reuptake inhibitors) are first-line choices, chosen for their relatively favourable side effect profiles. Response takes 4-6 weeks to become apparent, and full response may take 12 weeks — which is why premature discontinuation is such a common obstacle to successful treatment. If one antidepressant does not produce adequate response after 6-8 weeks at therapeutic dose, switching to a different medication or augmenting with a second agent are both evidence-based options.

Exercise has the strongest evidence of any lifestyle intervention for depression — multiple meta-analyses show effects comparable to antidepressants for mild to moderate depression. The mechanism involves BDNF increase, HPA axis regulation, endorphin release, and the behavioural activation component of simply engaging in a structured activity.

When to Seek Help and Who to See

One of the most consistent findings in depression research is that the longer depression goes untreated, the harder it becomes to treat and the more impairment it causes. Depression is not a condition that most people recover from through willpower and time alone, particularly at moderate to severe levels. Understanding when and how to seek help removes a significant barrier.

Seek help immediately if you are having thoughts of suicide or self-harm. Call 988 (US), go to an emergency room, or contact someone you trust right now. Suicidal thinking is a symptom of severe depression — it is not a rational assessment of your situation, and it is highly responsive to treatment.

Seek help within days if your symptoms have persisted for two weeks or more, are significantly interfering with your work, relationships, or self-care, or include feelings of profound hopelessness. Depression at this level does not reliably resolve without intervention.

Who to see: A psychiatrist is a medical doctor who specialises in mental health, can diagnose depression, prescribe medication, and often provide therapy. A psychologist holds a doctoral degree in psychology, can diagnose and provide evidence-based therapy, but typically cannot prescribe medication. A licenced therapist or counsellor can provide therapy but not diagnosis or medication. Your GP or primary care physician can screen for depression, prescribe antidepressants, and refer you to specialists — and is often the most accessible first point of contact.

When you see a clinician, be specific about your symptoms. "I have been feeling depressed" is less useful than "I have been feeling persistently hopeless for six weeks, I am sleeping twelve hours a day but waking exhausted, I have stopped doing things I used to enjoy, and I am having difficulty concentrating at work." The more concrete your description, the better the clinical picture — and the better the treatment decision.